An ASSOCHAM report projects India's pharma market to cross USD 120 billion by 2030, driven by global exports, AI drug discovery, biosimilars, and a shift from generics to core biotech innovation.

Executives at argenex (NASDAQ:ARGX) told investors at a Goldman Sachs healthcare event that they continue to see meaningful ...

Experts highlight clues that help identify drug-induced alopecia and outline treatment strategies tailored to the underlying ...

Kozhikode: Three individuals currently under quarantine have been hospitalised for medical observation, and their biological ...

BETHESDA, VA, UNITED STATES, June 12, 2026 /EINPresswire.com/ -- Integrating Bioinformatics, Machine Learning, and ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

AI could make bioweapons easier to build. A rare coalition wants to stop that now.

In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it ...

For many people who suffer from depression, the condition is not just about feeling down but also about a loss of motivation ...

Organon & Co. OGN recently announced that the FDA has approved a supplemental Biologics License Application (sBLA) for ...

Alzheimer’s disease is the most common cause of dementia, affecting millions of people worldwide. It gradually damages brain ...